Dave Hoon
机构: Professor and Director of Dept. of Translational Molecular Medicine at the Saint John’s Cancer
每年引用次数
引用次数
引用: 71,673
H-指数: 120
I10-指数 : 378
出版物: 692
Method for predicting response of cancer patient to chemotherapy
英幹 石原 , Dave S Hoon , Hidemiki Ishihara , Armando E Giuliano
1
2009
Characterization of FOLH1 expression in renal cell carcinoma (RCC).
Elizabeth Pan , Andrew Elliott , Shankar Siva , Praful Ravi
Journal of Clinical Oncology 41 ( 6_suppl) 713 -713
2
2023
The genomic, transcriptomic, and immunological landscape of TROP2 in solid tumors.
Asaad Trabolsi , Samuel A Kareff , Estelamari Rodriguez , Harris Benjamin Krause
Journal of clinical oncology 41 ( 16_suppl) 3118 -3118
1
2023
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes
Brian Warnecke , Misako Nagasaka , Mohammed Najeeb Al Hallak , Sahar Bannoura
Journal of Clinical Oncology 41 ( 16_suppl) 3128 -3128
1
2023
Tissue-specific thresholds and microenvironment correlates of tumor mutation burden associated with immunotherapy benefit and prognosis in microsatellite stable cancers
Maishara Muquith , Magdalena Espinoza , Andrew Elliott , Joanne Xiu
Cancer Research 84 ( 6_Supplement) 1213 -1213
2024
Topical therapy for regression and melanoma prevention of congenital giant nevi
Yeon Sook Choi , Tal H Erlich , Max von Franque , Inbal Rachmin
Cell 185 ( 12) 2071 -2085. e12
17
2022
Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma
Xiaoqing Zhang , Matias A Bustos , Rebecca Gross , Romela Irene Ramos
Cancer Research 82 ( 12_Supplement) 3233 -3233
2022
Early loss of monoubiquitylation of histone H2B alters key immune signaling pathways promoting the progression of high-grade serous ovarian cancer
Jagmohan Hooda , Marian Novak , Matthew P Salomon , Emily MacDuffie
CLINICAL CANCER RESEARCH 25 ( 22) 146 -146
2
2019
Extracellular vesicles transfer miR-181a to confer PARP inhibitor resistance and induce STING degradation in BRCA-mutated triple-negative breast and ovarian cancers cells
Matias A Bustos , Takamichi Yokoe , Yoshiaki Shoji , Yuta Kobayashi
Cancer Research 84 ( 6_Supplement) 2013 -2013
2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Hunter D Reavis , Stefan M Gysler , Grace B McKenney , Matthew Knarr
JCI insight 9 ( 5)
2024
Abstract AP23: EARLY LOSS OF MONOUBIQUITYLATION OF HISTONE H2B ALTERS KEY IMMUNE SIGNALING PATHWAYS PROMOTING THE PROGRESSION OF HIGH-GRADE SEROUS OVARIAN CANCER
Jagmohan Hooda , Marián Novak , Matthew P Salomon , Emily MacDuffie
Clinical Cancer Research 25 ( 22_Supplement) AP23 -AP23
2019
Molecular and immunologic characterization of HRAS mutations in a cohort of 6,329 patients with cutaneous melanoma
Leonel F Hernandez-Aya , Estelamari Rodriguez , Aparna Nallagangula , Jun Yin
Cancer Research 82 ( 12)
2022
Patient derived xenograft (PDX) of human melanoma to predict clinical responses
Clemens Krepler , Katrin Sproesser , Patricia Brafford , Min Xiao
Cancer Research 74 ( 19_Supplement) 1182 -1182
2014
Abstract LB218: MRE11A expression regulated by UBQLN4 is related to cisplatin-resistance and survival in patients with esophageal squamous cell carcinoma
Tomohiro Murakami , Yoshiaki Shoji , Tomohiko Nishi , Shu-Ching Chang
Cancer Research 81 ( 13_Supplement) LB218 -LB218
2021
Molecular characteristics and clinical outcomes of breast cancer with HRAS mutations.
Samuel Kareff , Estelamari Rodriguez , Richa Dawar , Asaad Trabolsi
Journal of Clinical Oncology 40 ( 16_suppl) 561 -561
1
2022
A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent
Maharrish Chelladurai , Dan Xu , Sivan Izraely , Shlomit Ben‐Menachem
International Journal of Cancer 154 ( 3) 561 -572
2024
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
Joanna Achinger-Kawecka , Fatima Valdes-Mora , Phuc-Loi Luu , Katherine A Giles
Nature Communications 11 ( 1) 320
84
2020
Transcriptomic signatures in melanoma lymph node metastasis that relate to immune oncology treatment
Matias A Bustos , Shodai Mizuno , Suyeon Ryu , Dave S Hoon
Cancer Research 83 ( 7_Supplement) 6375 -6375
2023
Circulating tumor cells isolated from non-small cell lung cancer patients using the in vivo CellCollector Technology
Thomas Krahn , Lukasz Gasiorowski , Wojciech Dyszkiewicz , Grzegorz Dworacki
Cancer Research 75 ( 15_Supplement) 1583 -1583
2015
Method for predicting response of cancer patient to anticancer drug treatment
Armando E Giuliano , Dave S Hoon , Hideki Ishihara
2010